Digital Pathology Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

Global digital pathology market is expected to register a CAGR of around 10% over the period of 2021-2027. The rising prevalence of chronic diseases is expected to increase the clinical urgency of adopting digital pathology to improve the patient's existing diagnostic imaging modality and reduce the high costs associated with the traditional diagnosis. In addition, an increasing population of elderly people who are prone to chronic diseases is expected to drive demand for technologically advanced diagnostic techniques. According to the World Health Organization, Cardiovascular diseases (CVDs) are the leading cause of death globally. An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Owing to the glaring statistics, rising prevalence of cardiovascular diseases (CVDs), it becomes imperative to opt for advanced diagnostic and imaging alternatives.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21674  

According to UnivDatos Market Insights (UMI)’ research report “global digital pathology market”, the market is expected to witness robust growth during the forecast period 2021-2027F. Advances in digital imaging, computerization, robot light microscopy, and multiple fiber optic communications are also contributing to growth. In addition, the adoption of AI in healthcare is increasing, with an increasing focus on improving the quality of patient care by using AI in various aspects of healthcare services, such as pathological diagnosis is used. AI-based tools, such as clinical decision support systems, can help streamline hospital workflows, improve healthcare, and thereby improving the patient experience. 

Based on application, the market is classified into teleconsultation, training, disease diagnosis, and drug discovery. Amongst application types, the drug discovery category accounted for a significant share of the market. The drug discovery category accounted for a significant share of the market due to an increase in the prevalence of rare diseases and growing R&D activities in the drug development process.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21674

 Based on end-user, the market is classified into pharmaceutical & biotechnology companies, academic and research, and hospitals. Amongst end-users, the pharmaceutical & biotechnology company’s category accounted for a significant share in the market due to the development of novel & innovative pathology systems, and advancement in R&D activities contributing to the growth of the market. 

North America to witness extensive growth

For a better understanding of the market adoption of digital pathology market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the digital pathology industry and generated major revenue in 2020 owing to the presence of well-established market players and the rising geriatric population in the region.

For more informative information, please visit us – https://univdatos.com/report/digital-pathology-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the global digital pathology market are 3dhistech Ltd., Danaher Corporation (Leica Microsystem), Glencoe Software Inc., Hamamatsu Photonics K.K., Indica Labs Inc., Koninklijke Philips N.V., Nikon Corporation, Perkinelmer Inc., F- Hoffmann La-Roche (Roche), Visiopharm A/S. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions. 

“Global Digital Pathology Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.      

For more informative information, please visit us –  https://univdatos.com/report/digital-pathology-market/

Market Segmentations:

1.     By Product Type (Scanner, Software, and Storage System)

2.     By Type (Human and Veterinary)

3.     By Application (Teleconsultation, Training, Disease Diagnosis, and Drug Discovery)

4.     By End-Users (Pharmaceutical & Biotechnology Companies, Academic and Research, and Hospitals)

5.     By Region (North America, Europe, Asia-Pacific, Rest of the World)

6.     By Company (3dhistech Ltd., Danaher Corporation (Leica Microsystem), Glencoe Software Inc., Hamamatsu Photonics K.K., Indica Labs Inc., Koninklijke Philips N.V., Nikon Corporation, Perkinelmer Inc., F- Hoffmann La-Roche, Visiopharm A/S.)  

Key questions answered in the study:

1.     What are the current and future trends of the global digital pathology industry?

2.     How the industry has been evolving in terms of technology and application?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the global digital pathology industry?

5.     What is the customer orientation, purchase behavior, and expectations from the global digital pathology suppliers across various region and countries? 

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL DIGITAL PATHOLOGY MARKET COVID-19 IMPACT

6 GLOBAL DIGITAL PATHOLOGY MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT TYPE

8 MARKET INSIGHTS BY TYPE

9 MARKET INSIGHTS BY APPLICATION

10 MARKET INSIGHTS BY END-USERS

11 MARKET INSIGHTS BY REGION

12 DIGITAL PATHOLOGY MARKET DYNAMICS

13 DIGITAL PATHOLOGY MARKET OPPORTUNITIES

14 DIGITAL PATHOLOGY MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

19 COMPANY PROFILED

20 DISCLAIMER 

Browse Other Related Research Reports from UnivDatos Market Insights

·       Ophthalmic Devices Market to Reach US$ 46.3 Billion by 2026, Globally |CAGR: 5.2%|

·       Continuous Positive Airway Pressure (CPAP) Device Market to Reach US$ 4 Billion by 2026, Globally |CAGR: 9% |

·       Artificial Intelligence (AI) in Healthcare Market to Reach US$ 26.5 Billion by 2025, Globally |CAGR: 41%|

·       In-Vitro Diagnostics (IVDs) Market to reach US$ 98 Billion by 2025, Globally |CAGR: 5.24%|